


@article{Wu2020ThFedratinib,
    author = {Wu, Dandan and Yang, Xuexian O},
    title = {TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib.},
    journal = {J Microbiol Immunol Infect},
    issn = {},
    year = {2020},
    volume = {},
    number = {},
    pages = {},
    doi = {10.1016/j.jmii.2020.03.005}
    citedbycount = {0},
    abstract = {COVID-19 emerges as a pandemic disease with high mortality. Development of effective prevention and treatment is an urgent need. We reviewed TH17 responses in patients with SARS-CoV-2 and proposed an FDA approved JAK2 inhibitor Fedratinib for reducing mortality of patients with TH17 type immune profiles.},
    keywords = {COVID-19, Cytokine storm, JAK2 inhibitor, SARS-CoV-2, TH17, high mortality}
}
